This interactive webinar will bring you the latest updates relevant to your clinical practice in the care of patients with psoriasis and psoriatic arthritis. CP-466485 | September 2024

TOPICS COVERED

Elevating PsO and PsA management: 2024 key data shaping future decisions
Objectives:

• Gain insight into new scientific advances in PsO and PsA treatment
• Review emerging data relating to the importance of early diagnosis and intervention, acknowledging inflammation across interconnected domains
• Understand the changing landscape in the diagnosis and treatment of patients with skin of colour

This medically led meeting is organised and fully funded by Johnson & Johnson, and is intended for UK and IE healthcare professionals only. Johnson & Johnson products may be discussed and Prescribing Information will be available at the meeting.
Adverse events associated with Janssen/ Johnson & Johnson company product should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Johnson & Johnson’s Drug Safety Department on 01494 567447 or at [email protected].
CP-466485 | September 2024

WHO SHOULD ATTEND?

UK healthcare professionals with an interest in rheumatology and/or dermatology

SPEAKERS

• Prof. Philip Helliwell – Professor of Clinical Rheumatology, University of Leeds
• Dr Laura Savage – Consultant Dermatologist and Honorary Senior Lecturer, Leeds Teaching Hospitals NHS Trust/University of Leeds

For more information, please contact: [email protected].